more than the the myx news - whats changed is funds are rotating out of growth stocks to value stocks
Thats why US FANG stocks are falling - the prospect of rising interest rates and faltering US gdp growth pushes investment back toward the 'defensive' stocks - healthcare, utilities, REITs
That - plus the very attractive valuation of MYX vs its peer group - should drive some big moves from here whilever overall market stays intact
MYX is v similar to TEVA in the US - TEVA just bottomed this week also
both stocks being caned for generics exposure for past few months, on ridiculously low p/es vs peer group, and with strong mgt and cashflow history.
MYX offers a superior PEGR though - I dont see any reason to think 1.30 wont be hit in next 2 months as long as US gdp data continues to be poor
Ann: FDA approval and first generic launch of Acticlate tablets, page-48
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.26 |
Change
0.090(2.16%) |
Mkt cap ! $362.4M | |||
| Open | High | Low | Value | Volume |
| $4.15 | $4.34 | $4.15 | $939.1K | 220.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 171 | $4.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.27 | 1207 | 2 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| MYX (ASX) Chart |